Predictive Value of CEA and ctDNA in Lung Cancer Recurrence

The study aims to investigate the predictive value of CEA levels for postoperative recurrence in the highly sensitive CEA lung cancer patients and to explore whether the dynamic changes of postoperative CEA and MRD in this population are related.This study was carried out to accurately predict the recurrence time, save the time and cost of changing the intervention strategy, and provide more personalized treatment for patients.

NCT Number	NCT07170046
Lead Sponsor	Guangdong Provincial People's Hospital
Conditions	Lung Carcinoma
Enrollment	100 participants
Start Date	2025-09-15
Primary Completion	2027-08-01 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2025-09-12